Profil
Mark L.
Thompson is the founder of Tribute Pharmaceuticals, Inc. (founded in 2006), Acerus Pharmaceuticals Corp.
(founded in 2008), and Advanz Pharma Corp.
Ltd.
(founded in 2010).
At Tribute Pharmaceuticals, he held the title of Vice President & General Counsel in 2008.
At Acerus Pharmaceuticals Corp., he held the title of Secretary & General Counsel from 2009 to 2011.
At Advanz Pharma Corp.
Ltd., he held the title of Chairman & Chief Executive Officer from 2015 to 2016.
Mr. Thompson's education includes an undergraduate and graduate degree from York University and a graduate degree from the University of Ottawa.
Anciens postes connus de Mark L. Thompson
| Sociétés | Poste | Fin |
|---|---|---|
| ADVANZ PHARMA CORP. LIMITED | Directeur Général | 14/11/2016 |
| ACERUS PHARMACEUTICALS CORPORATION | Fondateur | 19/12/2011 |
Tribute Pharmaceuticals, Inc.
 Tribute Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tribute Pharmaceuticals is a specialty pharmaceutical company engaged in the acquisition, licensing and management of pharmaceuticals products in Canada. Tribute is committed to providing patients and physicians with clinically proven pharmaceuticals products that treat recognized medical conditions and diseases. Their goal is to provide quality products that improve patient outcomes. Tribute is seeking to expand its product portfolio in Canada through strategic partnerships with other pharmaceutical, biotechnology and specialty pharmaceutical companies interested in gaining market experience in Canada. | Fondateur | 01/01/2008 |
Formation de Mark L. Thompson
| York University | Graduate Degree |
| University of Ottawa | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Acerus Pharmaceuticals Corp.
 Acerus Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Acerus Pharmaceuticals Corp. is a pharmaceutical company. The firm is focused on the commercialization and development of prescription products that improve patient experience, with a focus in the field of men’s health. It focuses on therapeutics for urology, andrology, and endocrinology. Its products include Estrace and Natesto. The company was founded by Bruce D. Brydon, Rolf K. Reininghaus and Mark L. Thompson on September 9, 2008 and is headquartered in Mississauga, Canada. | Health Technology |
Tribute Pharmaceuticals, Inc.
Tribute Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tribute Pharmaceuticals is a specialty pharmaceutical company engaged in the acquisition, licensing and management of pharmaceuticals products in Canada. Tribute is committed to providing patients and physicians with clinically proven pharmaceuticals products that treat recognized medical conditions and diseases. Their goal is to provide quality products that improve patient outcomes. Tribute is seeking to expand its product portfolio in Canada through strategic partnerships with other pharmaceutical, biotechnology and specialty pharmaceutical companies interested in gaining market experience in Canada. | Health Technology |
Advanz Pharma Corp. Ltd.
 Advanz Pharma Corp. Ltd. Pharmaceuticals: MajorHealth Technology ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company engages in the provision of branded and unbranded products. The firm specializes in anti-Infectives and endocrinology therapy areas. It operates through the following segments: Advanz Pharma International; Advanz Pharma North America; and Corporate. The Advanz Pharma International segment include portfolio of branded and generic products that are sold to wholesalers, hospitals, and pharmacies. The Advanz Pharma North America segment comprises branded products and authorized generic contracts that focuses primarily on the U.S. pharmaceutical market. The Corporate segment represents the centralized costs. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in St. Helier, the United Kingdom. | Health Technology |
